As of April 22, 2026, Akebia Therapeutics's top three insider holders are John P. Butler (Ceo And President, 3.37Mn shares), Erik Ostrowski (Svp, Cfo, Cbo Treasurer, 672.63K shares), Michel Dahan (Svp, Chief Operating Officer, 672.09K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| John P. Butler | Ceo And President | 3,367,064 | 0 | 05 Mar, 2026 |
| Erik Ostrowski | Svp, Cfo, Cbo Treasurer | 672,635 | 0 | 04 Feb, 2026 |
| Michel Dahan | Svp, Chief Operating Officer | 672,092 | 0 | 14 May, 2024 |
| Nicole R. Hadas | Svp, Chief Legal Officer | 651,243 | 0 | 14 May, 2024 |
| Carolyn M. Rucci | Svp, Chief Legal Officer | 588,378 | 0 | 04 Feb, 2026 |
| Nicholas Grund | Chief Commercial Officer | 561,750 | 0 | 04 Feb, 2026 |
| Ellen Snow | Svp, Cfo And Treasurer | 519,300 | 0 | 02 Feb, 2024 |
| David A Spellman | Svp, Cfo And Treasurer | 446,483 | 0 | 18 May, 2023 |
| Richard C Malabre | Svp, Chief Accounting Officer | 299,390 | 0 | 04 Feb, 2026 |
| Violetta Cotreau | Svp, Chief Accounting Officer | 219,954 | 0 | 16 May, 2022 |
| Adrian Adams | - | 200,500 | 0 | 11 Jun, 2025 |
| Dell Faulkingham | Svp, Cco | 173,841 | 0 | 02 Mar, 2022 |
| Michael W Rogers | - | 161,729 | 0 | 11 Jun, 2025 |
| Cynthia Smith | - | 160,933 | 0 | 11 Jun, 2025 |
| Myles Wolf | - | 133,381 | 0 | 11 Jun, 2025 |
| Ron Frieson | - | 129,500 | 0 | 11 Jun, 2025 |
| Leanne M Zumwalt | - | 109,400 | 0 | 11 Jun, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 01 Apr, 2026 | Philip J. Vickers | Stock Option (Right to buy) | A | 214,400 | $0.00 | 214,400 | D | A |
| 04 Mar, 2026 | John P. Butler | Common Stock | A | 69,270 | $1.25 | 3,367,064 | D | P |
| 02 Feb, 2026 | Carolyn M. Rucci | Common Stock | D | 16,846 | $1.39 | 641,304 | D | S |
| 02 Feb, 2026 | Richard C Malabre | Common Stock | D | 36,142 | $1.39 | 312,772 | D | S |
| 02 Feb, 2026 | Erik Ostrowski | Common Stock | D | 34,951 | $1.39 | 672,635 | D | S |
| 02 Feb, 2026 | Steven Keith Burke | Common Stock | D | 21,582 | $1.39 | 994,508 | D | S |
| 02 Feb, 2026 | John P. Butler | Common Stock | D | 46,660 | $1.39 | 3,417,189 | D | S |
| 02 Feb, 2026 | Nicholas Grund | Common Stock | D | 53,585 | $1.39 | 592,994 | D | S |
| 02 Feb, 2026 | John P. Butler | Common Stock | D | 96,065 | $1.39 | 3,321,124 | D | S |
| 02 Feb, 2026 | Carolyn M. Rucci | Common Stock | D | 25,382 | $1.39 | 615,922 | D | S |
| 02 Feb, 2026 | Nicholas Grund | Common Stock | D | 31,244 | $1.39 | 561,750 | D | S |
| 02 Feb, 2026 | Steven Keith Burke | Common Stock | D | 25,375 | $1.39 | 969,133 | D | S |
| 02 Feb, 2026 | Richard C Malabre | Common Stock | D | 13,382 | $1.39 | 299,390 | D | S |
| 02 Feb, 2026 | John P. Butler | Common Stock | D | 114,891 | $1.39 | 3,206,233 | D | S |
| 02 Feb, 2026 | Carolyn M. Rucci | Common Stock | D | 27,544 | $1.39 | 588,378 | D | S |
| 02 Feb, 2026 | Steven Keith Burke | Common Stock | D | 20,701 | $1.39 | 948,432 | D | S |
| 02 Feb, 2026 | John P. Butler | Common Stock | A | 175,250 | $1.41 | 3,381,483 | D | A |
| 02 Feb, 2026 | John P. Butler | Common Stock | D | 83,689 | $1.39 | 3,297,794 | D | S |
| 30 Jan, 2026 | Steven Keith Burke | Common Stock | A | 204,000 | $0.00 | 1,016,090 | D | A |
| 30 Jan, 2026 | Erik Ostrowski | Common Stock | A | 204,000 | $0.00 | 707,586 | D | A |